These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 9270575)

  • 1. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
    Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.
    Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy.
    Schwartz JR; Feldman NT; Bogan RK; Nelson MT; Hughes RJ
    Clin Neuropharmacol; 2003; 26(5):252-7. PubMed ID: 14520165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M; Black J
    CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.
    Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A
    J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
    Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ
    Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI; Black JE; Schwartz JR; Matheson JK
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
    Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
    Talbot K; Stradling J; Crosby J; Hilton-Jones D
    Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.
    Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R
    Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.